Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Novo Nordisk A/S
Woman and Man Max 99 years
Novo Nordisk A/S
Update Il y a 4 ans
A trial comparing the efficacy and safety of insulin degludec three times weekly in insulin naïve subjects with type 2 diabetes mellitus when titrated using two different titration algorithms
To confirm the efficacy of the IDeg 200U/ml 3 times weekly (3TW) simple titration algorithm + metformin in controlling glycaemia with respect to change from baseline glycosylated haemaglobin (HbA1c) a...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Novo Nordisk A/S
Update Il y a 4 ans
Effect of liraglutide on body weight in obese subjects without diabetes. A 20-week randomised, double-blind, placebo-controlled, six armed parallel group, multi-centre, multinational trial with an open label orlistat comparator arm with an 84 week extension period Trial Phase:2b
To investigate the efficacy of liraglutide to induce weight loss
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Novo Nordisk A/S
Update Il y a 4 ans
A randomised, double-blind, placebo-controlled, parallel-group trial to assess clinical efficacy and safety of NNC0114-0006 in subjects with active Crohn’s disease
To compare the effect on disease activity of a single i.v. dose of NNC0114-0006 with placebo in subjects with moderately to severely active Crohn’s disease
Country
None
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Novo Nordisk A/S
Update Il y a 4 ans
Multi-Centre, Open-Label, Randomised Trial Investigating the Pharmacokinetics of a Single Dose of NNC 0155-0000-0004 (N8) in Patients with Haemophilia A
To evaluate the pharmacokinetics (PK) of two different lots of N8 after a single intravenous (i.v.) administration of 50 IU/kg b.w. in patients with haemophilia A.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Novo Nordisk A/S
Update Il y a 4 ans
A 26 week randomised, open labelled, parallel group, multi-national, treat-to-target trial comparing efficacy and safety of insulin detemir once daily in combination with sitagliptin and metformin versus sitagliptin and metformin with or without sulphonylurea, in subjects with type 2 diabetes
To compare glycaemic control, measured as HbA1c, of insulin detemir given once daily in combination with sitagliptin and metformin versus sitagliptin and metformin ± SU after a 26-week treatment perio...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Novo Nordisk A/S
Update Il y a 4 ans
An extension trial to NN1250-3585 investigating safety and efficacy of NN1250 compared to insulin detemir in subjects with type 1 diabetes mellitus in a basal/bolus treatment regimen
The primary objective is to investigate the long-term safety and tolerability of NN1250 in combination with insulin aspart. This is done by comparing NN1250 to insulin detemir, both in combination wit...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Novo Nordisk A/S
Update Il y a 4 ans
Outcome Trial Evaluating the Efficacy and Safety of Norditropin® in Adult Patients on Chronic Haemodialysis A Randomised, Double-blind, Parallel group, placebo controlled, Multi-centre trial
To evaluate and establish the effect of Norditropin® (somatropin) on mortality in adult patients on chronic haemodialysis
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Novo Nordisk A/S
Update Il y a 4 ans
A trial investigating the mechanism of action of NNC0109-0012 (anti-IL-20 mAb) through synovial biopsies in subjects with rheumatoid arthritis and an inadequate response to Methotrexate
To explore the potential differences in the mechanism of action through analysis of synovial biopsies in subjects with active rheumatoid arthritis (RA) and an inadequate response to methotrexate (MTX)...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Novo Nordisk A/S
Update Il y a 4 ans
A randomised, parallel-group, open-labelled, multinational trial comparing the efficacy and safety of insulin detemir (Levemir®) versus human insulin (NPH insulin), used in combination with insulin aspart as bolus insulin, in the treatment of pregnant women with type 1 diabetes Trial Phase: 3b
To compare the glycaemic control measured as HbA1c obtained by using either insulin detemir or NPH insulin at gestational week (GW) = 36 (P4).
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Novo Nordisk A/S
Update Il y a 4 ans
A trial, in which subjects with type 2 diabetes, who qualify for treatment intensification, are given insulin degludec and, additionally, either liraglutide or insulin aspart, both in combination with metformin, with the largest meal. The purpose is to compare efficacy and safety of these two treatments
To compare the efficacy of adding liraglutide versus adding IAsp to the largest meal on top of IDeg OD + metformin in controlling glycaemia.
Country
None
organs
None
Specialty
None
Closed trial
More information
Previous
4
5
6
7
8
9
10
11
12
13
Next